Zemprocitinib, a next-generation JAK1 inhibitor, may tame rheumatoid arthritis that does not respond to at least one biologic disease-modifying antirheumatic drug, a phase 3 clinical trial finds.

Surveyed oncologists reported high likelihood to prescribe (6 of 7), citing deep remissions, transplant-bridging potential, biomarker-agnostic ...

SunMo demonstrated superior progression-free survival and overall response for mosunetuzumab plus polatuzumab vedotin versus ...

The investigational drug extends progression-free survival in a phase 3 trial in patients with platinum-resistant or -refractory ovarian cancer.

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced a new collaboration ...

The study enrolled 63 participants in more than a dozen countries around the world, inclusive of U.S. patients. The primary and key secondary efficacy endpoints in the study were the change from ...

Natera NTRA recently announced a collaboration with Diakonos Oncology to incorporate its Signatera molecular residual disease ...

Current therapies for rheumatoid arthritis rely on sustained immunosuppression rather than restoration of immune tolerance, with off-drug remission remaining rare. Recent anecdotal reports suggest ...

Multiple myeloma is considered to be relapsed if symptoms of the disease appear after a time of improvement. It’s considered to be refractory when it gets worse even though it’s being treated. To ...

Global Refractory Material Market Global Refractory Material Market Dublin, April 08, 2022 (GLOBE NEWSWIRE) -- The "Refractory Material Market by form, Chemical Composition, Chemistry and End Use: ...

Refractory has always been an integral part on any steam-generating boiler. Refractory materials are used for filling gaps and openings to keep the fire inside the furnace, lining ash hoppers (wet and ...

Majority of patients who received TIPS had a complete clinical response ...